BRIEF-US FDA Sends Warning Letter To Immunitybio For "False Or Misleading" TV Ad And Podcast On Anktiva

Reuters03-24

March 24 (Reuters) - US FDA:

US FDA: SENDS WARNING LETTER TO IMMUNITYBIO, INC FOR "FALSE OR MISLEADING" TV AD AND PODCAST ON ANKTIVA
US FDA : IMMUNITYBIO ADS "MISLEADINGLY" CLAIMS ANKTIVA CAN CURE, PREVENT ALL CANCER-WEBSITE

Further company coverage: IBRX.O

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2621885099?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-24 23:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2621885099","market":"fut","top_or_hot":-1,"title":"BRIEF-US FDA Sends Warning Letter To Immunitybio For \"False Or Misleading\" TV Ad And Podcast On Anktiva","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-US FDA Sends Warning Letter To Immunitybio For \"False Or Misleading\" TV Ad And Podcast On Anktiva</title></head><body><p><span>March 24 (Reuters)</span><span> - </span>US FDA: </p><ul><li><p>US FDA: SENDS WARNING LETTER TO IMMUNITYBIO, INC FOR \"FALSE OR MISLEADING\" TV AD AND PODCAST ON ANKTIVA</p></li><li><p>US FDA : IMMUNITYBIO ADS \"MISLEADINGLY\" CLAIMS ANKTIVA CAN CURE, PREVENT ALL CANCER-WEBSITE</p></li></ul><p>Further company coverage: <span>IBRX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-US FDA Sends Warning Letter To Immunitybio For \"False Or Misleading\" TV Ad And Podcast On Anktiva</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-US FDA Sends Warning Letter To Immunitybio For \"False Or Misleading\" TV Ad And Podcast On Anktiva\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-24 23:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-US FDA Sends Warning Letter To Immunitybio For \"False Or Misleading\" TV Ad And Podcast On Anktiva</title></head><body><p><span>March 24 (Reuters)</span><span> - </span>US FDA: </p><ul><li><p>US FDA: SENDS WARNING LETTER TO IMMUNITYBIO, INC FOR \"FALSE OR MISLEADING\" TV AD AND PODCAST ON ANKTIVA</p></li><li><p>US FDA : IMMUNITYBIO ADS \"MISLEADINGLY\" CLAIMS ANKTIVA CAN CURE, PREVENT ALL CANCER-WEBSITE</p></li></ul><p>Further company coverage: <span>IBRX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nFWN40C0O8:1","article_id":"2621885099","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2621885099","pubTimestamp":1774366437,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-US FDA Sends Warning Letter To Immunitybio For \"False Or Misleading\" TV Ad And Podcast On AnktivaMarch 24  - US FDA: US FDA: SENDS WARNING LETTER TO IMMUNITYBIO, INC FOR \"FALSE OR MISLEADING\" TV AD AND PODCAST ON ANKTIVAUS FDA : IMMUNITYBIO ADS \"MISLEADINGLY\" CLAIMS ANKTIVA CAN CURE, PREVENT ALL CANCER-WEBSITEFurther company coverage: IBRX.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","IBRX":"ImmunityBio, Inc."},"translate_title":"简报-美国FDA就Anktiva上的“虚假或误导性”电视广告和播客向Immunitybio发出警告信","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IBRX":0.9},"content_text":"BRIEF-US FDA Sends Warning Letter To Immunitybio For \"False Or Misleading\" TV Ad And Podcast On AnktivaMarch 24 (Reuters) - US FDA: US FDA: SENDS WARNING LETTER TO IMMUNITYBIO, INC FOR \"FALSE OR MISLEADING\" TV AD AND PODCAST ON ANKTIVAUS FDA : IMMUNITYBIO ADS \"MISLEADINGLY\" CLAIMS ANKTIVA CAN CURE, PREVENT ALL CANCER-WEBSITEFurther company coverage: IBRX.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2621885099","isCrawlerRequest":true}